Patients Object To Cigna’s $500 Incentive To Switch Drugs

By John Wilkerson / April 16, 2021 at 5:35 PM
Sixty-plus groups representing patients with disabilities and chronic diseases are objecting to a recent policy change by Cigna that they say the insurer uses to coerce non-medical switching of drugs. Cigna is using a $500 debit card to encourage members to switch to Cigna-preferred drugs. At issue is Cosentyx, a brand biologic for multiple rheumatic diseases with a list price that has increased significantly in recent years. After Cigna removed the drug from its preferred drug list, there were news...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.